ECDCX
Price
$5.41
Change
+$0.03 (+0.56%)
Updated
Apr 23 closing price
Net Assets
20.99M
VGIVX
Price
$25.54
Change
+$0.17 (+0.67%)
Updated
Apr 23 closing price
Net Assets
5.48B
Ad is loading...

ECDCX vs VGIVX

Header iconECDCX vs VGIVX Comparison
Open Charts ECDCX vs VGIVXBanner chart's image
Ashmore Emerging Mkts Corp Inc C
Price$5.41
Change+$0.03 (+0.56%)
VolumeN/A
Net Assets20.99M
Vanguard Emerging Mkts Govt Bd Idx Instl
Price$25.54
Change+$0.17 (+0.67%)
VolumeN/A
Net Assets5.48B
ECDCX vs VGIVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECDCX vs. VGIVX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECDCX is a Sell and VGIVX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VGIVX has more cash in the bank: 5.48B vs. ECDCX (21M). VGIVX pays higher dividends than ECDCX: VGIVX (6.30) vs ECDCX (4.93). ECDCX was incepted earlier than VGIVX: ECDCX (14 years) vs VGIVX (10 years). ECDCX (2.20) is less costly to investors than VGIVX (0.13). ECDCX is a more actively managed with annual turnover of: 95.00 vs. VGIVX (24.00). ECDCX has a lower initial minimum investment than VGIVX: ECDCX (1000) vs VGIVX (5000000). VGIVX annual gain was more profitable for investors over the last year : 7.07 vs. ECDCX (6.51). VGIVX return over 5 years is better than : 15.78 vs. ECDCX (8.01).
ECDCXVGIVXECDCX / VGIVX
Total Expense Ratio1.870.131,438%
Annual Report Gross Expense Ratio2.200.131,692%
Fund Existence14 years10 years-
Gain YTD0.1030.73914%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets21M5.48B0%
Annual Yield % from dividends4.936.3078%
Returns for 1 year6.517.0792%
Returns for 3 years3.0413.0123%
Returns for 5 years8.0115.7851%
Returns for 10 years15.4730.3551%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
C66.301.75
+2.71%
Citigroup
AQST2.810.06
+2.18%
Aquestive Therapeutics
IKNA1.210.02
+1.68%
Ikena Oncology
GSBD10.670.15
+1.43%
Goldman Sachs BDC
CHX24.57-0.41
-1.64%
ChampionX Corp